| 000 | 01838 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514040125.0 | ||
| 264 | 0 | _c20020806 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a0098-1532 | ||
| 024 | 7 |
_a10.1002/mpo.10047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJakab, Zsuzsanna | |
| 245 | 0 | 0 |
_aVariant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)? _h[electronic resource] |
| 260 |
_bMedical and pediatric oncology _cJul 2002 |
||
| 300 |
_a63-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 11 _xgenetics |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 4 _xgenetics |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aCytogenetic Analysis |
| 650 | 0 | 4 |
_aDNA Primers _xchemistry |
| 650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMercaptopurine _xadministration & dosage |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aBalogh, Erzsébet | |
| 700 | 1 | _aKarászi, Eva | |
| 700 | 1 | _aKappelmayer, János | |
| 700 | 1 | _aKiss, Csongor | |
| 700 | 1 | _aOláh, Eva | |
| 773 | 0 |
_tMedical and pediatric oncology _gvol. 39 _gno. 1 _gp. 63-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mpo.10047 _zAvailable from publisher's website |
| 999 |
_c12007202 _d12007202 |
||